Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
about
Molecular underpinnings of corneal angiogenesis: advances over the past decadeExtracellular Matrix, a Hard Player in AngiogenesisThe dual role of tumor lymphatic vessels in dissemination of metastases and immune response developmentCooperative inhibitory effect of sinomenine combined with 5-fluorouracil on esophageal carcinomaLamstatin--a novel inhibitor of lymphangiogenesis derived from collagen IVThe interplay of extracellular matrix and microbiome in urothelial bladder cancer.Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.Recombinant canstatin inhibits VEGF-A-induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC-VII animal model.Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.Tumour vasculature targeting agents in hybrid/conjugate drugs.Collagen-mediated hemostasis.Corosolic Acid Exhibits Anti-angiogenic and Anti-lymphangiogenic Effects on In Vitro Endothelial Cells and on an In Vivo CT-26 Colon Carcinoma Animal Model.Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanoma.Honokiol-loaded polymeric nanoparticles: an active targeting drug delivery system for the treatment of nasopharyngeal carcinoma.
P2860
Q26747539-FD4A598A-2FE4-4FF9-9C73-1A217C83237CQ28072886-04F5E0F3-B7F9-4C2A-8EED-A12FEEA167A0Q28076945-FDF45637-222D-4731-9F31-75C23FC9798FQ35074273-375D9722-AF0B-48A8-8AC1-0DAB9C3C8095Q35370419-C8257C67-248F-4295-AC1A-BF93B3FD461AQ35868405-80E2DC3F-9F43-499C-9242-1D46A9DD583EQ36808641-4D14AE7D-EBBF-4694-A504-4197C8494230Q37373141-60FA35C1-2F34-4393-A9DD-2EAB59AE0BB4Q37699417-FDB7A795-69A0-45A8-8BB5-0BE99B05D0A6Q38094627-C8EB5DD5-A4EF-4DC9-848B-E332571D4F0CQ38691485-378CFA8D-BF0D-40A0-9669-9AC30B60D4F4Q38913806-B2FCA69B-B6FD-4ABF-B89D-41416E2B6B89Q40638741-65454B8C-F044-4BBD-BFFB-D74FE9214E64Q52778677-CF3BA8AD-BC6A-42D6-A2FA-995D90D98EC1
P2860
Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
@en
Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
@nl
type
label
Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
@en
Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
@nl
prefLabel
Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
@en
Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
@nl
P2093
P2860
P356
P1476
Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
@en
P2093
Han-Sin Jeong
In Sik Chung
Jeon Hwang-Bo
Jong-Hwa Park
Ki Hyun Yoo
P2860
P304
P356
10.1002/IJC.26353
P577
2011-08-30T00:00:00Z